New leader at the helm of Novartis Hungária
An important change has taken place in the pharmaceutical industry: as of September 1, Novartis Hungária Kft. is under new leadership. According to the company's announcement, Mohamed Tammam has taken over the position of Country President.
The previous leader, Colette Matz, has stepped down from the post, and the specialist will succeed her in managing the company's operations in Hungary. This transition marks the beginning of a new era in the life of the company.
The arrival of Mohamed Tammam may bring about the continuation and potential renewal of the pharmaceutical company's domestic strategy. Novartis is one of the world's leading pharmaceutical manufacturers, which also conducts significant research and development activities in Hungary.
The company remains committed to supporting patients in Hungary, and its goal is to provide innovative therapies for the domestic healthcare system. The change in leadership does not affect the company's daily operations or ongoing projects.
According to market experts, the personnel change is in line with Novartis's international strategy. In the coming months, it is expected to become clear what specific goals the new Country President will set for himself in the Hungarian market.